BridgeBio Oncology Therapeutics, Inc. Share Price
NASDAQ: BBOT | Micro CapBridgeBio Oncology Therapeutics, Inc. Stock Performance
BridgeBio Oncology Therapeutics, Inc. Share Price Today
As of 29 October 2026, BridgeBio Oncology Therapeutics, Inc.'s share price is $2.82. The stock opened at $2.75, compared to its previous close of $2.79. During today's trading session, BridgeBio Oncology Therapeutics, Inc.'s share price traded between $2.75 and $2.88, with an average price of $2.81. Over the past 52 weeks, the stock has recorded a high of $14.56 and a low of $2.52. In terms of performance, BridgeBio Oncology Therapeutics, Inc.'s share price has declined by 66.39% over the last six months and is down 76.28% on a year-on-year basis.
BridgeBio Oncology Therapeutics, Inc. Share Price Chart
BridgeBio Oncology Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
BridgeBio Oncology Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About BridgeBio Oncology Therapeutics, Inc.
BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. The Company operates in one operating and reportable segment within the United States, developing oncology therapies through various related development projects.
BridgeBio Oncology Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $4.06 | $2.81 | -31.36% |
Sep 2026 | $8.63 | $4.09 | -55.35% |
Aug 2026 | $8.38 | $9.17 | +13.21% |
Jul 2026 | $7.75 | $8.10 | +6.30% |
Jun 2026 | $8.66 | $7.62 | -14.96% |
May 2026 | $8.40 | $8.96 | +6.79% |
Apr 2026 | $9.06 | $8.39 | -6.26% |
Mar 2026 | $10.00 | $8.95 | -10.54% |
Feb 2026 | $11.76 | $10.01 | -14.85% |
Jan 2026 | $12.05 | $11.75 | -5.55% |
Dec 2025 | $13.12 | $12.44 | +1.43% |
Nov 2025 | $12.02 | $12.27 | +3.15% |